354 related articles for article (PubMed ID: 32192753)
21. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O
Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496
[TBL] [Abstract][Full Text] [Related]
22. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.
Huang K; Vinik O; Shojania K; Yeung J; Shupak R; Nimmo M; Avina-Zubieta JA
Rheumatol Int; 2019 Nov; 39(11):1971-1981. PubMed ID: 31375890
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
Yamaguchi K; Yamaguchi A; Onuki Y; Itai M; Kashiwagi C; Takehara K; Aoki S; Kanaya A; Taguchi K; Umetsu K; Oshima K; Uchida M; Kimura H; Kasahara M; Takemura M; Hara K; Sekiguchi A; Motegi SI; Muro Y; Nakasatomi M; Motohashi R; Sakairi T; Nakagawa J; Hiromura K; Obokata M; Kurabayashi M; Maeno T
Mod Rheumatol; 2021 Jan; 31(1):177-185. PubMed ID: 32149542
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature.
Yamazaki S; Shimizu M; Yakabe A; Inage E; Jimbo K; Suzuki M; Miyaoka F; Kaneko S; Irabu H; Shimbo A; Ohtomo Y; Mori M; Morio T; Shimizu T
Immunol Med; 2024 Jun; 47(2):110-117. PubMed ID: 38557269
[TBL] [Abstract][Full Text] [Related]
25. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
[TBL] [Abstract][Full Text] [Related]
26. The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.
Osawa T; Morimoto K; Sasaki Y; Matsuda S; Yamana K; Yano R; Uchiyama T; Goto H
Intern Med; 2018 Feb; 57(3):387-391. PubMed ID: 29093381
[TBL] [Abstract][Full Text] [Related]
27. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
[TBL] [Abstract][Full Text] [Related]
28. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
Girard C; Vincent T; Bessis D
Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
[TBL] [Abstract][Full Text] [Related]
29. A Case of Dermatomyositis with Severe Myalgia and Muscle Weakness Testing Positive for Anti-melanoma Differentiation-associated Gene 5 Antibody.
Yamazaki K; Wakabayashi H; Suganami Y; Sano S; Wakunami Y; Katayama T; Deguchi K; Nagotani S; Kishida M
Acta Med Okayama; 2017 Aug; 71(4):341-344. PubMed ID: 28824190
[TBL] [Abstract][Full Text] [Related]
30. Case report: Successful treatment of anti-MDA5-positive to negative dermatomyositis-associated interstitial lung disease with the JAK inhibitor tofacitinib.
Jiang Z; Yao X; Tang F; Ma W
Immun Inflamm Dis; 2023 Jun; 11(6):e897. PubMed ID: 37382261
[TBL] [Abstract][Full Text] [Related]
31. [Interstitial lung disease-associated with amyopathic dermatomyositis and anti-MDA5 autoantibodies].
Gerfaud-Valentin M; Ahmad K; Piegay F; Fabien N; Raphanel B; Cordier JF; Cottin V
Rev Mal Respir; 2014 Nov; 31(9):849-53. PubMed ID: 25433590
[TBL] [Abstract][Full Text] [Related]
32. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
[TBL] [Abstract][Full Text] [Related]
33. [Fatal interstitial lung disease and pneumocystis during dermatomyositis associated with anti-MDA5 antibodies].
Seiller H; Schmutz JL; Poreaux C; Bursztejn AC
Ann Dermatol Venereol; 2020 Dec; 147(12):862-867. PubMed ID: 33131899
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant.
Chan CWS; Chung HY; Lau CS; Tsang HHL
Int J Rheum Dis; 2019 Mar; 22(3):521-524. PubMed ID: 28580698
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy.
Abe Y; Kusaoi M; Tada K; Yamaji K; Tamura N
Rheumatology (Oxford); 2020 Apr; 59(4):767-771. PubMed ID: 31504956
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment.
Shirakashi M; Nakashima R; Tsuji H; Tanizawa K; Handa T; Hosono Y; Akizuki S; Murakami K; Hashimoto M; Yoshifuji H; Ohmura K; Mimori T
Rheumatology (Oxford); 2020 Nov; 59(11):3284-3292. PubMed ID: 32276271
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
38. Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.
Fujita Y; Fukui S; Suzuki T; Ishida M; Endo Y; Tsuji S; Takatani A; Igawa T; Shimizu T; Umeda M; Sumiyoshi R; Nishino A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Abe K; Kawakami A
Intern Med; 2018 Dec; 57(23):3473-3478. PubMed ID: 29984753
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
[TBL] [Abstract][Full Text] [Related]
40. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases.
Mehta AA; Paul T; Cb M; Haridas N
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33910791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]